Assessment of community functioning in people with schizophrenia and other severe mental illnesses

A white paper based on an NIMH-sponsored workshop

Alan S. Bellack, Michael F. Green, Judith A. Cook, Wayne Fenton, Philip D Harvey, Robert K. Heaton, Thomas Laughren, Andrew C. Leon, Donna J. Mayo, Donald L. Patrick, Thomas L. Patterson, Andrew Rose, Ellen Stover, Til Wykes

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

People with schizophrenia frequently have significant problems in community functioning. Progress in developing effective interventions to ameliorate these problems has been slowed by the absence of reliable and valid measures that are suitable for use in clinical trials. The National Institute of Mental Health convened a workgroup in September 2005 to examine this issue and make recommendations to the field that would foster research in this area. This article reports on issues raised at the meeting. Many instruments have been developed to assess community functioning, but overall insufficient attention has been paid to psychometric issues and many instruments are not suitable for use in clinical trials. Consumer self-report, informant report, ratings by clinicians and trained raters, and behavioral assessment all can provide useful and valid information in some circumstances and may be practical for use in clinical trials. However, insufficient attention has been paid to when and how different forms of assessment and sources of information are useful or how to understand inconsistencies. A major limiting factor in development of reliable and valid instruments is failure to develop a suitable model of functioning and its primary mediators and moderators. Several examples that can guide thinking are presented. Finally, the field is limited by the absence of an objective gold standard of community functioning. Hence, outcomes must be evaluated in part by "clinical significance." This criterion is problematic because different observers and constituencies often have different opinions about what types of change are clinically important and how much change is significant.

Original languageEnglish
Pages (from-to)805-822
Number of pages18
JournalSchizophrenia Bulletin
Volume33
Issue number3
DOIs
StatePublished - Sep 1 2007
Externally publishedYes

Fingerprint

National Institute of Mental Health (U.S.)
Schizophrenia
Clinical Trials
Education
Psychometrics
Self Report
Research

Keywords

  • Assessment
  • Outcomes
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Assessment of community functioning in people with schizophrenia and other severe mental illnesses : A white paper based on an NIMH-sponsored workshop. / Bellack, Alan S.; Green, Michael F.; Cook, Judith A.; Fenton, Wayne; Harvey, Philip D; Heaton, Robert K.; Laughren, Thomas; Leon, Andrew C.; Mayo, Donna J.; Patrick, Donald L.; Patterson, Thomas L.; Rose, Andrew; Stover, Ellen; Wykes, Til.

In: Schizophrenia Bulletin, Vol. 33, No. 3, 01.09.2007, p. 805-822.

Research output: Contribution to journalArticle

Bellack, AS, Green, MF, Cook, JA, Fenton, W, Harvey, PD, Heaton, RK, Laughren, T, Leon, AC, Mayo, DJ, Patrick, DL, Patterson, TL, Rose, A, Stover, E & Wykes, T 2007, 'Assessment of community functioning in people with schizophrenia and other severe mental illnesses: A white paper based on an NIMH-sponsored workshop', Schizophrenia Bulletin, vol. 33, no. 3, pp. 805-822. https://doi.org/10.1093/schbul/sbl035
Bellack, Alan S. ; Green, Michael F. ; Cook, Judith A. ; Fenton, Wayne ; Harvey, Philip D ; Heaton, Robert K. ; Laughren, Thomas ; Leon, Andrew C. ; Mayo, Donna J. ; Patrick, Donald L. ; Patterson, Thomas L. ; Rose, Andrew ; Stover, Ellen ; Wykes, Til. / Assessment of community functioning in people with schizophrenia and other severe mental illnesses : A white paper based on an NIMH-sponsored workshop. In: Schizophrenia Bulletin. 2007 ; Vol. 33, No. 3. pp. 805-822.
@article{2faa645d5bb24557b9931d3f08ed240a,
title = "Assessment of community functioning in people with schizophrenia and other severe mental illnesses: A white paper based on an NIMH-sponsored workshop",
abstract = "People with schizophrenia frequently have significant problems in community functioning. Progress in developing effective interventions to ameliorate these problems has been slowed by the absence of reliable and valid measures that are suitable for use in clinical trials. The National Institute of Mental Health convened a workgroup in September 2005 to examine this issue and make recommendations to the field that would foster research in this area. This article reports on issues raised at the meeting. Many instruments have been developed to assess community functioning, but overall insufficient attention has been paid to psychometric issues and many instruments are not suitable for use in clinical trials. Consumer self-report, informant report, ratings by clinicians and trained raters, and behavioral assessment all can provide useful and valid information in some circumstances and may be practical for use in clinical trials. However, insufficient attention has been paid to when and how different forms of assessment and sources of information are useful or how to understand inconsistencies. A major limiting factor in development of reliable and valid instruments is failure to develop a suitable model of functioning and its primary mediators and moderators. Several examples that can guide thinking are presented. Finally, the field is limited by the absence of an objective gold standard of community functioning. Hence, outcomes must be evaluated in part by {"}clinical significance.{"} This criterion is problematic because different observers and constituencies often have different opinions about what types of change are clinically important and how much change is significant.",
keywords = "Assessment, Outcomes, Schizophrenia",
author = "Bellack, {Alan S.} and Green, {Michael F.} and Cook, {Judith A.} and Wayne Fenton and Harvey, {Philip D} and Heaton, {Robert K.} and Thomas Laughren and Leon, {Andrew C.} and Mayo, {Donna J.} and Patrick, {Donald L.} and Patterson, {Thomas L.} and Andrew Rose and Ellen Stover and Til Wykes",
year = "2007",
month = "9",
day = "1",
doi = "10.1093/schbul/sbl035",
language = "English",
volume = "33",
pages = "805--822",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Assessment of community functioning in people with schizophrenia and other severe mental illnesses

T2 - A white paper based on an NIMH-sponsored workshop

AU - Bellack, Alan S.

AU - Green, Michael F.

AU - Cook, Judith A.

AU - Fenton, Wayne

AU - Harvey, Philip D

AU - Heaton, Robert K.

AU - Laughren, Thomas

AU - Leon, Andrew C.

AU - Mayo, Donna J.

AU - Patrick, Donald L.

AU - Patterson, Thomas L.

AU - Rose, Andrew

AU - Stover, Ellen

AU - Wykes, Til

PY - 2007/9/1

Y1 - 2007/9/1

N2 - People with schizophrenia frequently have significant problems in community functioning. Progress in developing effective interventions to ameliorate these problems has been slowed by the absence of reliable and valid measures that are suitable for use in clinical trials. The National Institute of Mental Health convened a workgroup in September 2005 to examine this issue and make recommendations to the field that would foster research in this area. This article reports on issues raised at the meeting. Many instruments have been developed to assess community functioning, but overall insufficient attention has been paid to psychometric issues and many instruments are not suitable for use in clinical trials. Consumer self-report, informant report, ratings by clinicians and trained raters, and behavioral assessment all can provide useful and valid information in some circumstances and may be practical for use in clinical trials. However, insufficient attention has been paid to when and how different forms of assessment and sources of information are useful or how to understand inconsistencies. A major limiting factor in development of reliable and valid instruments is failure to develop a suitable model of functioning and its primary mediators and moderators. Several examples that can guide thinking are presented. Finally, the field is limited by the absence of an objective gold standard of community functioning. Hence, outcomes must be evaluated in part by "clinical significance." This criterion is problematic because different observers and constituencies often have different opinions about what types of change are clinically important and how much change is significant.

AB - People with schizophrenia frequently have significant problems in community functioning. Progress in developing effective interventions to ameliorate these problems has been slowed by the absence of reliable and valid measures that are suitable for use in clinical trials. The National Institute of Mental Health convened a workgroup in September 2005 to examine this issue and make recommendations to the field that would foster research in this area. This article reports on issues raised at the meeting. Many instruments have been developed to assess community functioning, but overall insufficient attention has been paid to psychometric issues and many instruments are not suitable for use in clinical trials. Consumer self-report, informant report, ratings by clinicians and trained raters, and behavioral assessment all can provide useful and valid information in some circumstances and may be practical for use in clinical trials. However, insufficient attention has been paid to when and how different forms of assessment and sources of information are useful or how to understand inconsistencies. A major limiting factor in development of reliable and valid instruments is failure to develop a suitable model of functioning and its primary mediators and moderators. Several examples that can guide thinking are presented. Finally, the field is limited by the absence of an objective gold standard of community functioning. Hence, outcomes must be evaluated in part by "clinical significance." This criterion is problematic because different observers and constituencies often have different opinions about what types of change are clinically important and how much change is significant.

KW - Assessment

KW - Outcomes

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=34547180551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547180551&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbl035

DO - 10.1093/schbul/sbl035

M3 - Article

VL - 33

SP - 805

EP - 822

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 3

ER -